vidarabine has been researched along with EHS Tumor in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Driscoll, JS; Kaskar, B; Khan, MS; Lim, MI; Markovac, A; Marquez, VE; Plowman, J; Priest, MA; Treanor, SP | 1 |
Fukuoka, F; Nishimura, S; Okabe, M; Saneyoshi, M | 1 |
Akagi, K; Sogawa, M; Tanaka, Y | 1 |
Brock, WA; Grégoire, V; Hittelman, WN; Hunter, N; Milas, L; Plunkett, W | 1 |
Kelleher, DK; Thews, O; Vaupel, P | 1 |
Brock, WA; Grégoire, V; Hittelman, WN; Hunter, NR; Milas, L; Plunkett, W | 1 |
LePage, GA | 1 |
Kimball, AP; LePage, GA; Worth, LS | 1 |
8 other study(ies) available for vidarabine and EHS Tumor
Article | Year |
---|---|
Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties.
Topics: 3-Deazauridine; Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Cytidine; DNA Viruses; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Orthomyxoviridae; RNA Viruses; Sarcoma, Experimental; Viruses | 1988 |
Synthetic nucleosides and nucleotides. XIV. Facile synthesis and antitumor activities of 6-mercaptopurine 2'-deoxyriboside and related compounds.
Topics: Animals; Antineoplastic Agents; Deoxyribonucleosides; Female; Mercaptopurine; Mice; Mice, Inbred ICR; Purine Nucleosides; Sarcoma 180; Sarcoma, Experimental; Thioinosine; Thionucleosides; Vidarabine; Vidarabine Phosphate | 1980 |
[Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
Topics: Animals; Cell Line; Cell Survival; Cyclophosphamide; Doxorubicin; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasms, Experimental; Radiation-Sensitizing Agents; Sarcoma, Experimental; Vidarabine | 1983 |
Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Topics: Animals; Antineoplastic Agents; Cell Division; Combined Modality Therapy; Drug Administration Schedule; Feasibility Studies; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sarcoma, Experimental; Vidarabine | 1994 |
In vivo oxygen consumption rate of DS sarcoma cells on inhibition of DNA synthesis.
Topics: Animals; Antineoplastic Agents; Ascites; Cell Division; Depression, Chemical; DNA, Neoplasm; Lovastatin; Male; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Vidarabine | 1996 |
Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
Topics: Animals; Antineoplastic Agents; Indomethacin; Male; Mice; Mice, Inbred C3H; Prostaglandin Antagonists; Sarcoma, Experimental; Vidarabine | 1996 |
Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells.
Topics: Animals; DNA, Neoplasm; Drug Resistance; Humans; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred C3H; Nucleic Acid Synthesis Inhibitors; Sarcoma, Experimental; Vidarabine | 1978 |
Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Azepines; Cytarabine; Deoxyribonucleosides; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Female; Leukemia L1210; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred Strains; Purine Nucleosides; Sarcoma, Experimental; Vidarabine | 1976 |